ASX CODE: MXC

MGC Pharmaceuticals ASX MXC cannabinoids brain cancer research cannabis

MGC Pharmaceuticals presents ‘ground-breaking’ research into effect of cannabis on brain cancer

Biopharmaceutical company MGC Pharmaceuticals (ASX: MXC) has completed what it calls “ground-breaking research” that highlights the effectiveness of cannabinoids on various brain cancers. Earlier today, the “seed...
MGC Pharma ASX MXC CannEpil UK epilepsy distribution

MGC Pharma officially enters UK with CannEpil distribution to begin immediately

Medicinal cannabis producer MGC Pharmaceuticals’ (ASX: MXC) first CannEpil shipment to the UK has landed on British soil and will be immediately distributed to...
MGC Pharmaceuticals ASX MXC nutraceuticals CBD Chinese health products YuShop Global

MGC Pharmaceuticals enters Chinese market with CBD products

Biopharmaceutical company MGC Pharmaceuticals (ASX: MXC) is entering the Chinese health market, inking a deal with e-commerce import platform YuShop Global to sell its...
MGC Pharmaceuticals ASX MXC TGA approval CannEpil medicinal cannabis product Australia

MGC Pharmaceuticals receives TGA approval to market its CannEpil medicinal cannabis product in Australia

Aspiring bio-pharmaceutical company MGC Pharmaceuticals (ASX: MXC) has received formal authorisation to supply its CannEpil product through specialist prescribers under the ‘Authorised Prescriber Scheme’...
MGC Pharmaceuticals ASX MXC cannabis potential treatment fight against dementia

MGC Pharmaceuticals positions cannabis as a potential treatment in the fight against dementia

Biopharma developer MGC Pharmaceuticals (ASX: MXC) plans to apply the potential benefits of cannabis to mitigate the impact of dementia. Earlier this morning, the company...
Harvey Nichols UK MGC Pharmaceuticals ASX MXC CBD Derma range cannabidiol

UK’s Harvey Nichols to expand MGC Pharmaceuticals CBD Derma range

MGC Pharmaceuticals (ASX: MXC) has received strong commercial news this morning with the news that UK-based retailer Harvey Nichols has decided to expand the...
MGC Pharmaceuticals ASX MXC GMP certificate manufacturing licence CannEpil

MGC Pharmaceuticals receives key medical cannabis certification and manufacturing licence

Biopharma company MGC Pharmaceuticals (ASX: MXC) has received its GMP certification and formal manufacturing licence to produce Good Manufacturing Practice (GMP) grade medical cannabis...
Malta medical cannabis legislation ASX MGC Pharmaceuticals MXC

MGC Pharmaceuticals celebrates medical cannabis legislative change in Malta

The final piece of its cannabis production line has now slotted into place for MGC Pharmaceuticals (ASX: MXC) after final legislation was passed by...
MGC Pharmaceutics ASX MGC CBD Herbal Replenish cream launched

MGC Pharmaceuticals launches latest cannabidiol skincare product

Medicinal cannabis and its expansive set of applications continue to encroach upon commercial markets with MGC Pharmaceuticals (ASX: MXC) launching yet another cannabidiol-based product...
MGC Pharma ASX MXC medical cannabis facility Malta

MGC Pharma gets go-ahead to build medical cannabis facility in Malta, tops up cash

MGC Pharma (ASX: MXC) has grown its medical cannabis production capabilities after the Maltese Government gave the company the go-ahead to construct and operate...
MGC Pharmaceuticals ASX MXC CannEpil production

MGC Pharmaceuticals commences production of CannEpil product for epilepsy

Medicinal cannabis is emerging into mainstream consumption, one approval at a time for MGC Pharmaceuticals (ASX: MXC). As one of the world’s most avant-garde market...
MGC Derma Pharma ASX MXC Cult Beauty

MGC Pharma’s cannabidiol cosmetics launch on Cult Beauty online store

Australian medicinal cannabis company MGC Pharmaceuticals (ASX: MXC) has officially launched its range of MGC Derma and Derma Plus cannabidiol (CBD) cosmetic and skin...
MGC Pharmaceuticals ASX MXC CannEpil medicinal cannabis Europe Good Manufacturing Practice

MGC Pharma granted green light to start manufacturing CannEpil for distribution

MGC Pharmaceuticals (ASX: MXC) has been given the greenlight to begin manufacturing its medicinal cannabis-based products at its European production facility, after receiving interim...
MGC Pharma ASX MXC Cult Beauty cannabis cosmetics distribution

MGC Pharma gains cosmetics distribution boost via Cult Beauty

MGC Pharmaceuticals (ASX: MXC), an Australian medicinal cannabis company, has announced that its European subsidiary MGC Derma has signed a sales and distribution agreement...
MGC Pharmaceuticals ASX MXC cannabis Derma Plus cream psoriasis

MGC Pharma’s cannabis-based herbal cream now available for psoriasis sufferers

MGC Pharmaceuticals (ASX: MXC) has officially launched its cannabidiol-based Derma Plus herbal cream for psoriasis sufferers throughout Australasia, the European Union and US. Patients in these regions...
MGC Pharma ASX MXC cannabis CBD-based psoriasis cream derma plus

MGC Pharma to launch CBD-based psoriasis cream next month

Psoriasis suffers will have a new treatment available from January 1st next year after MGC Pharmaceuticals (ASX: MXC) scheduled the launch for its cannabidiol-based...
MGC Pharmaceuticals ASX MXC CBD extract supply Mabsut Life

MGC Pharmaceuticals secures CBD extract supply agreement worth $1m

MGC Pharmaceuticals (ASX: MXC) has secured yet another supply agreement, this time with European distributor Mabsut Life, with this contract, alone, expected to generate...
MGC Pharmaceutical MXC ASX Australian market epilepsy drug CannEpil

MGC Pharma breaks into Australian pharmaceutical market with epilepsy drug

MGC Pharmaceuticals (ASX: MXC) has inked a heads of agreement with Australian distributor HL Pharma Pty Ltd to distribute its CannEpil product to Australian...
MGC Pharmaceuticals MXC Varm Cosmo sales agreement cannabis

MGC signs $8m cosmetics sales agreement with Varm Cosmo, more to come

MGC Pharmaceuticals (ASX: MXC) has inked its first exclusive binding sales agreement worth A$8 million to supply Korean cosmetics manufacturer Varm Cosmo with cannabidiol...
MGC Pharmaceuticals MXC cannabis cosmetics

MGC Pharmaceuticals signs $40 million supply agreement for its cannabis cosmetics

Medical cannabis company MGC Pharmaceuticals (ASX: MXC) has clinched a supply agreement for its cannabidiol (CBD) cosmetics with Varm Cosmo, which is expected to...
MGC Pharmaceuticals MXC European medicinal cannabis distribution agreement

MGC Pharmaceuticals signs European medicinal cannabis distribution agreement

Medical grade cannabis developer MGC Pharmaceuticals’ (ASX: MXC) stock was up 5% in early afternoon trade after it announced it had signed a five-year...

RECENT POSTS

STOCK SUMMARY

HOT TOPICS

TRENDING POSTS